MiraVista Diagnostics Email Format
Hospitals and Health CareIndiana, United States51-200 Employees
MiraVista Diagnostics is a CAP- and CLIA-certified reference laboratory focused on developing and processing diagnostic tests for invasive fungal infections. It emphasizes collaboration among its research, clinical, and production teams to broaden testing options for patients. Founded in 2002 by infectious disease scientist Dr. Lawrence Joseph Wheat, who contributed to the development of the first Histoplasma antigen test, MiraVista serves medical and veterinary sectors worldwide with antigen and antibody detection for Coccidioides, Histoplasma capsulatum, Aspergillus, Blastomyces dermatitidis, Cryptococcus, Beta-D Glucan, and Pneumocystis DNA PCR. Based in Indianapolis, Indiana, the laboratory provides same-day results and direct access to infectious disease specialists who have collectively published more than 1,000 scientific articles. Its client base includes research hospitals, health care institutions, universities, national reference laboratories, and veterinary clinics. In 2018 the company announced an expansion of its Indianapolis operations to accommodate growth.